INNOVUS PHARMACEUTICALS, INC. Proceeds from Stock Options Exercised
INNOVUS PHARMACEUTICALS, INC. reported Proceeds from Stock Options Exercised of $2.85 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2018-11-14
- INNOVUS PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2018-09-30 was $13.95K, a 602.77% increase year-over-year.
- INNOVUS PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2018-06-30 was $0.00.
- INNOVUS PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2018-03-31 was $2.84M, a 97990.91% increase year-over-year.
- INNOVUS PHARMACEUTICALS, INC. proceeds from stock options exercised for the quarter ending 2017-09-30 was $1.99K, a 99.36% decline year-over-year.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month |
|---|---|---|---|
| 2018-09-30 | $13.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $13.95K derived: sum of 2 quarters · filed 2018-11-14 | $2.85M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $2.84M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.84M 10-Q · filed 2018-05-14 | ||
| 2017-09-30 | $1.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.99K derived: sum of 2 quarters · filed 2018-11-14 | $4.88K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $2.89K 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $2.89K 10-Q · filed 2018-05-14 | ||
| 2016-09-30 | $310.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $310.14K derived: sum of 2 quarters · filed 2017-11-14 | $310.14K 10-Q · filed 2017-11-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 |